Clinical Trial Update: Allopurinol as a Possible Oxygen Sparing Agent During Exercise in Peripheral Arterial Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating allopurinol as a potential oxygen-sparing agent during exercise in peripheral arterial disease has completed. The study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: University of Dundee | Conditions: Peripheral Arterial Disease | Phase 4 | Status: COMPLETED